Dana Goldman
#75,713
Most Influential Person Now
American academic
Dana Goldman's AcademicInfluence.com Rankings
Download Badge
Economics
Dana Goldman's Degrees
- PhD Economics Stanford University
- Bachelors Economics Cornell University
Similar Degrees You Can Earn
Why Is Dana Goldman Influential?
(Suggest an Edit or Addition)According to Wikipedia, Dana Paul Goldman is the dean of the USC Price School of Public Policy, Leonard D. Schaeffer Chair and director of the University of Southern California Leonard D. Schaeffer Center for Health Policy and Economics, and Professor of Public Policy, Pharmacy, and Economics at the Price School and USC School of Pharmacy. He is also an adjunct professor of health services and radiology at UCLA, and a managing director and founding partner, along with Darius Lakdawalla and Tomas J. Philipson, at Precision Heath Economics, a health care consulting firm. Previously held positions include the director of the Bing Center for Health Economics, RAND Royal Center for Health Policy Simulation, and UCLA/RAND Health Services Research Postdoctoral Training Program.
Dana Goldman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Participation of patients 65 years of age or older in cancer clinical trials. (2003) (962)
- Prescription drug cost sharing: associations with medication and medical utilization and spending and health. (2007) (789)
- Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. (1999) (768)
- Differences in life expectancy due to race and educational differences are widening, and many may not catch up. (2012) (630)
- Pharmacy benefits and the use of drugs by the chronically ill. (2004) (563)
- Can patient self-management help explain the SES health gradient? (2002) (547)
- Heterogeneity in healthy aging. (2014) (305)
- Are the Young Becoming More Disabled? (2001) (284)
- Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. (2001) (276)
- Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study. (2000) (270)
- Employer drug benefit plans and spending on prescription drugs. (2002) (243)
- Substantial health and economic returns from delayed aging may warrant a new focus for medical research. (2013) (231)
- Estimating probit models with self‐selected treatments (2006) (210)
- The health and cost consequences of obesity among the future elderly. (2005) (199)
- Impact of oral nutritional supplementation on hospital outcomes. (2013) (191)
- Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy. (2006) (185)
- Consequences of health trends and medical innovation for the future elderly. (2005) (182)
- Insulin Access and Affordability Working Group: Conclusions and Recommendations (2018) (174)
- National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sample. (1999) (172)
- Aging in America in the twenty-first century: demographic forecasts from the MacArthur Foundation Research Network on an Aging Society. (2009) (171)
- Patient cost-sharing and healthcare spending growth. (2011) (167)
- HIV Breakthroughs and Risk Sexual Behavior (2004) (157)
- Legal status and health insurance among immigrants. (2005) (154)
- Immigrants and the cost of medical care. (2006) (151)
- Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. (2001) (150)
- Political polarization in US residents’ COVID-19 risk perceptions, policy preferences, and protective behaviors (2020) (128)
- Benefit design and specialty drug use. (2006) (123)
- Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims (2014) (120)
- The increasing value of education to health. (2011) (119)
- The Link between Public and Private Insurance and Hiv-Related Mortality (2002) (114)
- Effect of Insurance on Mortality in an HIV-Positive Population in Care (2001) (114)
- Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre study (2019) (112)
- Out-of-pocket medication costs and use of medications and health care services among children with asthma. (2012) (109)
- Does age or life expectancy better predict health care expenditures? (2008) (106)
- Hospital Spending and Inpatient Mortality: Evidence From California (2011) (105)
- Assessment of Follow-up Care After Emergency Department Presentation for Mild Traumatic Brain Injury and Concussion (2018) (97)
- High out-of-pocket health care spending by the elderly. (2003) (96)
- Estimated prevalence of undiagnosed atrial fibrillation in the United States (2018) (94)
- Identifying, Categorizing, and Evaluating Health Care Efficiency Measures (2008) (91)
- The lifetime burden of chronic disease among the elderly. (2005) (89)
- A Theory of Health Disparities and Medical Technology (2005) (88)
- The benefits of risk factor prevention in Americans aged 51 years and older. (2009) (85)
- Undiagnosed disease, especially diabetes, casts doubt on some of reported health 'advantage' of recent Mexican immigrants. (2012) (80)
- Integrated Insurance Design in the Presence of Multiple Medical Technologies (2007) (80)
- Understanding Health Disparities Across Education Groups (2001) (79)
- Can medical savings accounts for the nonelderly reduce health care costs? (1996) (78)
- Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population. (2012) (78)
- An Economic Evaluation of the War on Cancer (2009) (78)
- The effect of regulation on pharmaceutical revenues: experience in nineteen countries. (2008) (77)
- Aligning incentives to fulfil the promise of personalised medicine (2015) (76)
- Toward a 21st-Century Health Care System: Recommendations for Health Care Reform (2009) (76)
- Sexually Transmitted Diseases Among Users of Erectile Dysfunction Drugs: Analysis of Claims Data (2010) (75)
- Medical Expenditure Risk and Household Portfolio Choice (2005) (72)
- Incidence of sexually transmitted infections after human papillomavirus vaccination among adolescent females. (2015) (72)
- Incremental treatment costs in national cancer institute-sponsored clinical trials. (2003) (71)
- Food Prices and the Dynamics of Body Weight (2009) (71)
- Hospital Prescribing of Opioids to Medicare Beneficiaries. (2016) (71)
- Economic Burden of Undiagnosed Nonvalvular Atrial Fibrillation in the United States. (2015) (70)
- An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer. (2012) (68)
- Effective HIV treatment and the employment of HIV(+) adults. (2004) (67)
- Managed care as a public cost-containment mechanism. (1995) (67)
- Prescription Drug Cost Sharing (2007) (64)
- Disability and health care spending among medicare beneficiaries. (2005) (62)
- Hospitals as Hotels: The Role of Patient Amenities in Hospital Demand (2008) (61)
- Disability Forecasts and Future Medicare Costs (2004) (60)
- How the Growing Gap in Life Expectancy May Affect Retirement Benefits and Reforms (2017) (60)
- Forecasting the Nursing Home Population (2003) (59)
- Racial and ethnic disparities in medication adherence among privately insured patients in the United States (2019) (59)
- Preparedness of Americans for the Affordable Care Act (2014) (59)
- Mortality and treatment patterns among patients hospitalized with acute cardiovascular conditions during dates of national cardiology meetings. (2014) (58)
- Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis. (2010) (57)
- The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment. (2012) (57)
- Geographic Variation in Health Care: The Role of Private Markets (2010) (56)
- Confounding in the Association of Proton Pump Inhibitor Use With Risk of Community-Acquired Pneumonia (2013) (55)
- Methodological biases in estimating the burden of out-of-pocket expenses. (2001) (54)
- How Costly is Hospital Quality? A Revealed‐Preference Approach (2008) (53)
- The value of specialty oncology drugs. (2010) (52)
- U.S. pharmaceutical policy in a global marketplace. (2008) (51)
- Differences in health between Americans and Western Europeans: Effects on longevity and public finance. (2011) (50)
- The Disability Burden of COPD (2012) (49)
- Socioeconomic Differences in the Adoption of New Medical Technologies (2005) (48)
- Early Failure of Dialysis Access among the Elderly in the Era of Fistula First. (2015) (47)
- The Association between Employee Obesity and Employer Costs: Evidence from a Panel of U.S. Employers (2014) (47)
- Association Between the Birth of Twins and Parental Divorce (2011) (46)
- Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA. (2010) (45)
- Terminal Care and the Value of Life Near its End (2010) (44)
- Preparing for an Aging World: Engaging Biogerontologists, Geriatricians, and the Society. (2016) (43)
- Growing Internet use may help explain the rise in prescription drug abuse in the United States. (2011) (42)
- Cost sharing and the initiation of drug therapy for the chronically ill. (2009) (42)
- Health Status and Medical Treatment of the Future Elderly: Final Report (1995) (42)
- Nearly 60,000 uninsured and low-income people with HIV/AIDS live in states that are not expanding Medicaid. (2014) (41)
- Health Status and Medical Treatment of the Future Elderly (2004) (41)
- The association between observed mobility and quality of life in the near elderly (2017) (41)
- The emerging importance of patient amenities in hospital care. (2010) (40)
- The Value of Elderly Disease Prevention (2006) (40)
- Point-of-Care Platform Blood Biomarker Testing of Glial Fibrillary Acidic Protein versus S100 Calcium-Binding Protein B for Prediction of Traumatic Brain Injuries: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study (2020) (39)
- Bending the curve: effective steps to address long-term healthcare spending growth. (2009) (37)
- Physician prescribing behavior and its impact on patient-level outcomes. (2011) (37)
- Health and Health Care of Medicare Beneficiaries in 2030 (2015) (37)
- Functional Outcomes Over the First Year After Moderate to Severe Traumatic Brain Injury in the Prospective, Longitudinal TRACK-TBI Study. (2021) (37)
- Obesity and Disability: The Shape of Things to Come (2007) (36)
- Broad Hepatitis C Treatment Scenarios Return Substantial Health Gains, But Capacity Is A Concern. (2015) (36)
- Simulating the impact of medical savings accounts on small business. (2000) (35)
- Price Variation in Markets with Homogeneous Goods: the Case of Medigap (2009) (34)
- Multidimensional comparison of countries’ adaptation to societal aging (2018) (34)
- Patients value metastatic cancer therapy more highly than is typically shown through traditional estimates. (2012) (34)
- The Effects of Relative Food Prices on Obesity -- Evidence from China: 1991-2006 (2010) (33)
- Prescription Drug Coverage and Elderly Medicare Spending (2007) (32)
- Prescription Medication Abuse and Illegitimate Internet-Based Pharmacies (2011) (32)
- Measuring the incremental cost of clinical cancer research. (2001) (32)
- Medicaid cost control measures aimed at second-generation antipsychotics led to less use of all antipsychotics. (2011) (32)
- Early HIV treatment led to life expectancy gains valued at $80 billion for people infected in 1996-2009. (2014) (32)
- U.S. Health Care: Facts About Cost, Access, and Quality (2005) (32)
- HIV care providers emphasize the importance of the Ryan White Program for access to and quality of care. (2014) (32)
- THE FISCAL CONSEQUENCES OF TRENDS IN POPULATION HEALTH (2010) (32)
- The value of medical and pharmaceutical interventions for reducing obesity. (2012) (31)
- Technological advances in cancer and future spending by the elderly. (2005) (31)
- The benefits from giving makers of conventional 'small molecule' drugs longer exclusivity over clinical trial data. (2011) (31)
- Racial and ethnic disparities in hospital care resulting from air pollution in excess of federal standards. (2011) (31)
- Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis (2015) (31)
- The potential impact of comparative effectiveness research on U.S. Health Care expenditures (2010) (30)
- Identifying potential health care innovations for the future elderly. (2005) (30)
- Cost-Containment and Adverse Selection in Medicaid HMOs (1998) (30)
- Do Physicians Respond to the Costs and Cost-Sensitivity of Their Patients? (2018) (30)
- Pharmacy benefit caps and the chronically ill. (2007) (29)
- The Impact of State Policy on the Costs of HIV Infection (2001) (29)
- The Growing Gap in Life Expectancy: Using the Future Elderly Model to Estimate Implications for Social Security and Medicare. (2014) (29)
- Using Self-reports or Claims to Assess Disease Prevalence: It’s Complicated (2017) (28)
- Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD (2012) (28)
- Encouraging New Uses for Old Drugs (2017) (27)
- Digesting the doughnut hole. (2013) (27)
- Clinical and Behavioral Correlates of Achieving and Maintaining Glycemic Targets in an Underserved Population With Type 2 Diabetes (2009) (27)
- Health Care Spending: Historical Trends and New Directions (2015) (26)
- Coverage and preventive screening. (2011) (26)
- A Socioeconomic Profile of Older Adults With HIV (2005) (26)
- Heterogeneity in action: the role of passive personalization in comparative effectiveness research. (2014) (26)
- The Impact of Air Quality on Hospital Spending. (2012) (26)
- The promise of health care cost containment. (2007) (25)
- Cancer mortality reductions were greatest among countries where cancer care spending rose the most, 1995-2007. (2015) (25)
- Hospital costs and inpatient mortality among children undergoing surgery for congenital heart disease. (2014) (25)
- Economic Value of Anti-Vascular Endothelial Growth Factor Treatment for Patients With Wet Age-Related Macular Degeneration in the United States. (2019) (25)
- Cost-sharing and initiation of disease-modifying therapy for multiple sclerosis. (2012) (24)
- Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in Medicaid. (2014) (24)
- US hospitals experienced substantial productivity growth during 2002-11. (2015) (24)
- Specialty drug spending trends among Medicare and Medicare Advantage enrollees, 2007-11. (2014) (24)
- Innovation in Heart Failure Treatment: Life Expectancy, Disability, and Health Disparities. (2018) (24)
- Impact of type 2 diabetes medication cost sharing on patient outcomes and health plan costs. (2016) (24)
- The effects of benefit design and managed care on health care costs. (1995) (23)
- Drug licenses: a new model for pharmaceutical pricing. (2008) (23)
- Early HIV treatment in the United States prevented nearly 13,500 infections per year during 1996-2009. (2014) (23)
- Medicare Part D: a successful start with room for improvement. (2008) (23)
- Price Regulation in Secondary Insurance Markets (2004) (23)
- Value of improved lipid control in patients at high risk for adverse cardiac events. (2016) (23)
- Spending and mortality in US acute care hospitals. (2013) (23)
- Impact of specialty drugs on the use of other medical services. (2008) (22)
- Insurance status of HIV-infected adults in the post-HAART era: evidence from the United States. (2003) (22)
- Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs. (2012) (22)
- Medicare part D after 2 years. (2009) (22)
- Employee responses to health insurance premium increases. (2004) (21)
- Improving the quality of care through routine teleradiology consultation. (2000) (21)
- The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000 (2010) (21)
- Disparities in Care for HIV Patients (2006) (20)
- Queuing for Surgery: Is the U.S. or Canada Worse Off? (2000) (20)
- Accelerating Alzheimer's disease drug innovations from the research pipeline to patients (2018) (20)
- The Value of Diagnostic Testing in Personalized Medicine (2013) (20)
- Evaluating Expected Costs and Benefits of Granting Access to New Treatments on the Basis of Progression-Free Survival in Non-Small-Cell Lung Cancer. (2015) (19)
- Opinion: Measuring how countries adapt to societal aging (2018) (19)
- Measuring The Lifetime Costs Of Serious Mental Illness And The Mitigating Effects Of Educational Attainment. (2019) (19)
- Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? (2019) (18)
- Projecting diabetes prevalence among Mexicans aged 50 years and older: the Future Elderly Model-Mexico (FEM-Mexico) (2017) (18)
- An economic analysis of conservative management versus active treatment for men with localized prostate cancer. (2012) (18)
- Medical Expenditure Measures in the Health and Retirement Study (2011) (18)
- The Impact of the US Food and Drug Administration Chlorofluorocarbon Ban on Out-of-pocket Costs and Use of Albuterol Inhalers Among Individuals With Asthma. (2015) (18)
- Variation in inpatient resource use in the treatment of HIV: do the privately insured receive more care? (1999) (18)
- Bending the curve through health reform implementation. (2010) (17)
- Do Statins Reduce the Health and Health Care Costs of Obesity? (2015) (17)
- Use of unpaid and paid home care services among people with HIV infection in the USA (2001) (17)
- The Long-Term Impact of Functional Disability on Hospitalization Spending in Singapore. (2019) (17)
- Job loss due to health insurance mandates. (1994) (17)
- Increased Medicare Expenditures for Physicians' Services: What are the Causes? (2004) (17)
- Medication adherence and measures of health plan quality. (2015) (16)
- The changing face of pharmacy benefit design. (2004) (15)
- Variations in outcomes of hemodialysis vascular access by race/ethnicity in the elderly (2017) (15)
- Heterogeneity in Cost-Sharing and Cost-Sensitivity, and the Role of the Prescribing Physician (2013) (15)
- Diabetes management for low-income patients in Los Angeles: two strategies improved disease control in the short term. (2012) (15)
- Heterogeneity in Cost-Sharing and Cost-Sensitivity, and the Role of the Prescribing Physician (2013) (15)
- Creating the Costliest Orphan: The Orphan Drug Act in the Development of Ceredase™ (1992) (15)
- Understanding the Economic Consequences of Shifting Trends in Population Health (2009) (15)
- How much savings can we wring from Medicare? (2011) (15)
- Are the young becoming more disabled?: Rates of disability appear to be on the rise among people ages eighteen to fifty-nine, fueled by a growing obesity epidemic (2004) (15)
- The costs of developing treatments for Alzheimer's disease: A retrospective exploration (2021) (14)
- The Economic Promise of Delayed Aging. (2016) (14)
- MARKET EVIDENCE OF MISPERCEIVED MORTALITY RISK. (2009) (14)
- Data-driven decision-making tools to improve public resource allocation for care and prevention of HIV/AIDS. (2014) (13)
- Long-Term Health and Economic Value of Improved Mobility among Older Adults in the United States. (2018) (13)
- Drug costs and out-of-pocket spending in cancer clinical trials. (2008) (13)
- The prospect of a generation free of HIV may be within reach if the right policy decisions are made. (2014) (13)
- The Relationship between Commercial Health Care Prices and Medicare Spending and Utilization. (2015) (12)
- Short-term budget affordability of hepatitis C treatments for state Medicaid programs (2019) (12)
- Disentangling Moral Hazard and Adverse Selection in Private Health Insurance (2016) (11)
- The Affordable Care Act and Health Insurance Coverage Among People With Diagnosed and Undiagnosed Diabetes: Data From the National Health and Nutrition Examination Survey (2019) (11)
- Redistributional consequences of community rating. (1997) (11)
- Opioid-related deaths before and after COVID-19 stay-at-home orders in Los Angeles County (2021) (11)
- The Effect of Regulation on Pharmaceutical Revenues (2009) (11)
- The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older (2016) (11)
- Coverage and use of cancer therapies in the treatment of chronic myeloid leukemia. (2012) (11)
- The determinants of recent gains in cancer survival: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database (2008) (11)
- Acute Myocardial Infarction Mortality During Dates of National Interventional Cardiology Meetings (2018) (11)
- Robot-assisted surgery for kidney cancer increased access to a procedure that can reduce mortality and renal failure. (2015) (11)
- The Lifecycle Benefits of an Influential Early Childhood Program (2017) (11)
- Adverse Selection in Retiree Prescription Drug Plans (2006) (10)
- Realizing the Full Potential of Precision Medicine in Health and Health Care: A Vital Direction for Health and Health Care (2016) (10)
- Did Medicare Part D reduce disparities? (2015) (10)
- Intellectual Property, Information Technology, Biomedical Research, and Marketing of Patented Products (2011) (10)
- The Value of Progression-Free Survival in Metastatic Breast Cancer: Results From a Survey of Patients and Providers (2019) (10)
- Frequency and Magnitude of Co-payments Exceeding Prescription Drug Costs (2018) (10)
- Predicting quantity and quality of life with the Future Elderly Model. (2020) (10)
- The Costs of A Medicare Prescription Drug Benefit (2002) (10)
- Outcomes-Based Pricing as a Tool to Ensure Access to Novel but Expensive Biopharmaceuticals (2017) (10)
- The Societal Value of Broader Access to Antiobesity Medications (2019) (9)
- The future of the elderly population health status: Filling a knowledge gap. (2021) (9)
- The potential impact of CAR T-cell treatment delays on society. (2019) (9)
- Association Between State Medicaid Eligibility Thresholds and Deaths Due to Substance Use Disorders. (2019) (9)
- Disentangling Moral Hazard and Adverse Selection in Private Health Insurance. (2020) (9)
- Smaller Regional Brain Volumes Predict Posttraumatic Stress Disorder at 3 Months After Mild Traumatic Brain Injury. (2020) (9)
- Future Health and Medical Care Spending of the Elderly (2005) (9)
- Delayed Aging Versus Delayed Disease: A New Paradigm for Public Health (2013) (8)
- Patterns of Enlisted Compensation (2001) (8)
- Criminal Prosecution and Human Immunodeficiency Virus–Related Risky Behavior (2010) (8)
- Competing Risks: Investing in Sickness Rather Than Health. (2016) (8)
- Three large-scale changes to the Medicare program could curb its costs but also reduce enrollment. (2013) (8)
- Lifetime Burden of Adult Congenital Heart Disease in the USA Using a Microsimulation Model (2020) (8)
- Managed care in dental markets: is the experience of medicine relevant? (1999) (8)
- Part D Formulary and Benefit Design as a Risk-Steering Mechanism. (2011) (7)
- Obesity and Disability (2004) (7)
- Identifying Patients at Risk for High Medical Costs and Good Candidates for Obesity Intervention (2014) (7)
- Retirement and Weight (2008) (7)
- Five myths about cancer care in America. (2014) (7)
- The Effects of Product Liability Exemption in the Presence of the Fda (2009) (7)
- Trends in Racial and Ethnic Disparities in Diabetes-Related Complications, 1997–2017 (2019) (7)
- Medicaid prior authorization policies and imprisonment among patients with schizophrenia. (2014) (7)
- Measuring the value of better diabetes management. (2013) (7)
- Complexity Bias in the Prevention of Iatrogenic Injury: Why Specific Harms May Inhibit Performance. (2022) (7)
- Effect of an imaging-based streamlined electronic healthcare process on quality and costs. (2004) (6)
- Rising medicare costs: are we in crisis? (2006) (6)
- International Differences in Longevity and Health and Their Economic Consequences (2009) (6)
- Resetting Social Security (2015) (6)
- Criminal Prosecution and Hiv-Related Risky Behavior (2007) (6)
- Erratum. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care 2018;41;1299–1311 (2018) (6)
- Access to HIV Care: Initial Results from the HIV Cost and Services Utilization Study (2000) (6)
- Association between exenatide use and incidence of Alzheimer's disease (2021) (6)
- Cutting Drug Co-Payments for Sicker Patients on Cholesterol-Lowering Drugs Could Save a Billion Dollars Every Year (2006) (6)
- Cost Sharing Cuts Employers' Drug Spending -- But Employees Don't Get the Savings (2002) (6)
- Association Between Spending and Outcomes for Patients With Cancer. (2019) (6)
- Looking Ahead to 2030: Survey of Evolving Needs in Pharmacy Education (2021) (6)
- Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection (2016) (6)
- Can the ACA Improve Population Health? (2010) (6)
- How Did the ACA ’ s Individual Mandate Affect Insurance Coverage ? Evidence from Coverage Decisions by Higher-Income People (2018) (5)
- Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017. (2019) (5)
- Evaluation of the CHAMPUS Reform Initiative. Volume 3, Health Care Utilization and Costs (1993) (5)
- Modeling the Health and Medical Care Spending of the Future Elderly (2008) (5)
- Economic Dimensions of Personalized and Precision Medicine (2019) (5)
- Determinants of Increases in Medicare Expenditures for Physicians' Services: (2003) (5)
- Geographic variation in the delivery of high-value inpatient care (2019) (5)
- The economics of alternative payment models for pharmaceuticals (2021) (5)
- Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants (2014) (5)
- PCSK9 Inhibitors Show Value for Patients and the US Health Care System. (2017) (5)
- The Effect of Pharmaceutical Regulation on Revenues (2008) (5)
- The Reallocation of Compensation in Response to Health Insurance Premium Increases (2003) (5)
- Moral Hazard and Adverse Selection in Private Health Insurance (2013) (5)
- Higher Surgeon Procedure Volume is Associated with Improved Hemodialysis Vascular Access Outcomes (2019) (5)
- HIV Treatment Breakthroughs and Risky Sexual Behavior (2006) (4)
- Varying Pharmacy Benefits with Clinical Status (2006) (4)
- How Costly Is Hospital Quality (2008) (4)
- Temporal Trends in Mortality after Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Regression Analysis (2020) (4)
- Providing managed care options for a large population: evaluating the CHAMPUS reform initiative. Civilian Health and Medical Program of the Uniformed Services. (2000) (4)
- Prescription Drug Coverage and Medicare Spending among U.S. Elderly (2010) (4)
- Effect of COVID-19 vaccine allocation strategies on vaccination refusal: a national survey (2021) (4)
- A New Model for Pricing Drugs of Uncertain Efficacy (2018) (4)
- Raising the Social Security Entitlement Age (2017) (4)
- Measuring Sarcopenia Severity in Older Adults and the Value of Effective Interventions (2018) (4)
- Can patient self-management explain the health gradient? Goldman and Smith (2002) revisited: a response to Maitra. (2010) (4)
- Clinical evidence inputs to comparative effectiveness research could impact the development of novel treatments. (2015) (4)
- A Reexamination of the Costs of Medical R&D Regulation (2012) (4)
- Patient Preference for Treatment Administration in Cystic Fibrosis (2015) (4)
- Increased Medicare Expenditures for Physicians' Services (2004) (4)
- The Impact of State AIDS Drug Assistance Policies on Clinical and Economic Outcomes of People With HIV (2016) (4)
- A response to the points by Manton and Williamson. (2003) (4)
- Introduction to "Economic Dimensions of Personalized and Precision Medicine" (2018) (4)
- Extended-Release Formulation and Medication Adherence (2019) (4)
- Do strict formularies replicate failure for patients with schizophrenia? (2014) (4)
- TEMPORAL TRENDS IN 30-DAY AND 1-YEAR MORTALITY RATES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: A SYSTEMATIC REVIEW AND META-REGRESSION ANALYSIS (2019) (4)
- Individual & Social Strategies to Mitigate the Risks & Expand Opportunities of an Aging America (2015) (4)
- Re: Surveys identify barriers to participation in clinical trials. (2001) (4)
- The Cost of Cancer Treatment Study's Design and Methods (2000) (3)
- Costs of a Medicare Prescription Drug Benefit: A Comparison of Alternatives (2002) (3)
- Preventing Obesity and Its Consequences: Highlights of RAND Health Research (2011) (3)
- ECONOMIC BURDEN OF UNDIAGNOSED NONVALVULAR ATRIAL FIBRILLATION IN THE UNITED STATES (2015) (3)
- Hospitals as Hotels (2008) (3)
- An Analysis of Unobserved Selection in an Inpatient Diagnostic Cost Group Model (2003) (3)
- The long-term social value of granulocyte colony-stimulating factors. (2019) (3)
- Consumer Demand and Health Effects of Cost-Sharing (2012) (3)
- Prognostic Value of Hemorrhagic Brainstem Injury on Early Computed Tomography: A TRACK-TBI Study (2021) (3)
- Prescription Drug Cost Sharing: A Powerful Policy Lever to Use with Care (2009) (3)
- Modelling the value of innovative treatments for Alzheimer’s disease in the United States (2021) (3)
- Improved survival for individuals with common chronic conditions in the Medicare population. (2020) (3)
- Who Pays in Medicare Part D? Giving Plans More Skin in the Game. (2019) (3)
- Regulating Drug Prices: U.S. Policy Alternatives in a Global Context (2008) (3)
- 1 Retirement and Weight (2008) (3)
- Society and the Individual at the Dawn of the Twenty-First Century (2016) (3)
- Tying Reimbursement to Outcomes Is an Ideal Strategy for PCSK9 Inhibitors (2017) (3)
- Interim Report: Evaluation of the Medicare-DoD Subvention Demonstration (1999) (3)
- Treating people right: Who goes untreated with systemic therapy for metastatic prostate cancer (mPC)? (2012) (3)
- Risk factors and costs associated with 30-day readmissions following alcohol-related hospitalizations in the US from 2010-2015. (2020) (3)
- THE ECONOMIC RETURNS TO DELAYED AGING: PROMISE AND PITFALLS (2017) (2)
- Moving towards better formulary management. (2005) (2)
- Want to Monitor Medicare's New Drug Benefit Program? Start by Sending a Check for $120,000 (2008) (2)
- A Systematic Review of the Adverse Effects of Prescription Drug Cost Sharing (2007) (2)
- Disability And Health Care Spending Among Medicare (2005) (2)
- Sampling Patients Within and Across Health Care Providers: Multi-Stage Non-Nested Samples in Health Services Research (2004) (2)
- Forecasting the nursing home population. Point and Counterpoint. Authors' reply (2003) (2)
- Using Hospital Tumor Registries to Identify Research Subjects (2001) (2)
- Timing is everything: time to ADT and chemotherapy initiation for treatment of metastatic prostate cancer (2012) (2)
- Are Biopharmaceutical Budget Caps Good Public Policy? (2016) (2)
- Valuing Health Technologies at NICE (2010) (2)
- Disparate ageing: The role of education and socioeconomic gradients in future health and disability in an international context. (2021) (2)
- Queuing for Surgery (2000) (2)
- Cost and Health Consequences of Air Pollution in California (2010) (2)
- Spending On Targeted Therapies Reduced Mortality In Patients With Advanced-Stage Breast Cancer. (2021) (2)
- Associations of Intensive Lifestyle Intervention in Type 2 Diabetes With Health Care Use, Spending, and Disability (2020) (2)
- Title : Private Insurance and Outcomes for Children with Asthma (2010) (2)
- Abstract 274: Prevalence of undiagnosed non-valvular atrial fibrillation in the United States (2014) (1)
- Time to ADT and chemotherapy initiation for treatment of metastatic prostate cancer (mPC). (2012) (1)
- A Look inside the "Doughnut Hole": How Drug-Benefit Limits Affect Retiree Prescription Use (2007) (1)
- Association between use of ß2-adrenergic receptor agonists and incidence of Parkinson’s disease: Retrospective cohort analysis (2022) (1)
- Use of physicians' services for Medicare beneficiaries. (2007) (1)
- Price Variation in Markets with Homogeneous Goods (2009) (1)
- Total Actual RVU Use by Beneficiary Age/Gender Categories, 1993 and 1998 (2003) (1)
- Emergency Department Visits for Ambulatory Care Sensitive Conditions: The Role of County-Level Primary Care Provider Density and Payer Status (2013) (1)
- Preventing Obesity and Its Consequences (2011) (1)
- Quantifying Productivity Growth in Health Care Using Insurance Claims and Administrative Data (2019) (1)
- Access to HIV Care (2000) (1)
- Health Insurance: Should California Regulate Health Insurance Premiums? (2004) (1)
- Abstract P4-20-02: Value of cancer care for metastatic breast cancer patients and providers (2017) (1)
- Health Care in California: A Policy Assessment (2004) (1)
- The social value of tisagenlecleucel, a CAR-T cell therapy, for the treatment of relapsed or refractory pediatric acute lymphoblastic leukemia in the United States: What are consequences of treatment delays? (2018) (1)
- The HSA Mirage (2006) (1)
- Quantifying Productivity Growth in the Delivery of Important Episodes of Care Within the Medicare Program Using Insurance Claims and Administrative Data (2020) (1)
- Three-Part Pricing to Reward Pharmaceutical Innovation and Increase Access: Case of PCSK9 Inhibitors (2018) (1)
- Want More Value from Prescription Drugs? We Need to Let Prices Rise and Fall (2013) (1)
- Job Loss Due to Health Care Reform (1994) (1)
- IT IS TIME FOR UNIVERSAL COVERAGE WITHOUT BREAKING THE BANK (2018) (1)
- Productivity Benefits of Medical Care: Evidence from US-Based Randomized Clinical Trials. (2018) (1)
- Historical Trends in Medicare Expenditure Growth (2003) (1)
- Comparative effectiveness research and formulary placement: the case of diabetes. (2013) (1)
- Simulating the Fiscal Impact of Anti-Obesity Medications as an Obesity Reduction Strategy (2021) (1)
- Chlorhexidine Rinse for Prevention of Urethritis in Men Linked to Oral Sex (2011) (1)
- Time to ADT and chemotherapy initiation for treatment of metastatic prostate cancer (mPC). (2012) (1)
- Practice Economics and the Decision to Prescribe Oral Oncolytics (2013) (1)
- U.S. Health Care (2005) (1)
- Considerations in the implementation of multicancer early detection tests. (2022) (1)
- Measuring the Adaptation of Countries to Societal Aging (2018) (1)
- The impact of broader hepatitis C treatment strategies on population health and social value in England (2017) (1)
- Benefit Design Should Reflect Value (2012) (1)
- Introducing Managed Care in the Military Health System (1999) (1)
- The Public Spends Little to Provide Health Care for Undocumented Immigrants (2006) (1)
- Disability and Spending Growth (2009) (1)
- Treating people right: Who goes untreated with systemic therapy for metastatic prostate cancer (mPC)? (2012) (1)
- Health Costs of Katrina (2005) (1)
- When Drug Cost-Sharing Increases, Patients Newly Diagnosed with a Chronic Illness Delay Starting Medication (2009) (1)
- How Cost Sharing Affects Use of Drugs by the Chronically Ill (2005) (1)
- A new method for determining patient payments for outpatient drugs. (2002) (1)
- Abstract 16196: The Economic Value of Statin Therapy (2011) (0)
- Formulary restrictions and stroke risk in patients with atrial fibrillation. (2022) (0)
- Take Two Aspirin and Call Congress (2002) (0)
- Hospital Productivity: The Authors Reply. (2015) (0)
- From Th e F ield Rising Medicare Costs: Are We In Crisis? (2006) (0)
- Issues in Employee Coverage and Use (2005) (0)
- In the face of rising health care spending, we must redouble our efforts to establish value for that spending. (2007) (0)
- Replication data for: Do Physicians Respond to the Costs and Cost-Sensitivity of Their Patients? (2019) (0)
- Societal Perspective: Comment (2006) (0)
- Table 22, Decomposing the predicted change in RVU for physician services use (2003) (0)
- Trends in Mortality, Morbidity and Healthcare Utilization: Does It Make Sense to Use Healthcare As a Proxy for Health? (2019) (0)
- Fix the Healthcare System (and Fight the Recession, Too) (2009) (0)
- Managed Care in Dental Markets (1999) (0)
- Payment for Physicians' Services Under the Resource Based Relative Value Scale (2003) (0)
- Spending and Inpatient Mortality in U.S. Acute Care Hospitals (2013) (0)
- Table 20, Probabilities of any use of physicians' services (2003) (0)
- Medicare MSA Issues and Options (1998) (0)
- Medicare Part D: A Successful Start with Room for Improvement Spending (2008) (0)
- Correction (2020) (0)
- Policy Options for European Pharmaceutical Markets (2018) (0)
- Job Loss Due to Health Care Reform: Testimony before the Senate Committee on Labor and Human Resources, October 19, 1993 (1994) (0)
- Medical Innovation And The Changing Health And Health Care Costs Of Obesity (2014) (0)
- Table 11, Sources of payments for other health professional services,selected calendar years, 1970-1999 (2003) (0)
- A Third-and Better-Way for Prescription-Drug Coverage (2000) (0)
- Preventing Complications of Central Venous Catheterization (2003) (0)
- PMU28 TRENDS IN MORTALITY BY DISEASE: CHANGES IN SURVIVAL RATES FOR THE MEDICARE FEE-FOR-SERVICE POPULATION (2019) (0)
- Book Review Who Should Pay for Medicare? By Daniel Shaviro. 169 pp. Chicago, University of Chicago Press, 2004. $25. 0-226-75076-0 (2004) (0)
- Table 14, Medicaid expenditure on physicians' services per recipient, 1990-1998, in 1990 constant dollars (2003) (0)
- Access To And Quality Of Care HIV Care Providers Emphasize The Importance Of The Ryan White Program For (2014) (0)
- Immigrants use disproportionately less medical care than their representation in the U.S. population would indicate. (2006) (0)
- Valuing innovations in cancer treatment. (2019) (0)
- Table 1, Balanced Budget Reconciliation Act (1999) mandates (2003) (0)
- Note from the Editor (2010) (0)
- Development of a Group Judgment Process for Forecasts of Health Care Innovations (2018) (0)
- Table 10, Sources of payments for physician and clinical services, selected calendar years, 1970-1999 (2003) (0)
- Policy Decisions Are Made The Prospect Of A Generation Free Of HIV May Be Within Reach If The Right Seekins (2014) (0)
- Table 19, RVU use by year and service categories, 1993 & 1998 (2003) (0)
- The Future of US Health Care: Is Medicare Really Better at “Saving” Money? (2014) (0)
- Table 8, Average annual growth in per enrollee Medicare and private health insurance expenditure for all services (2003) (0)
- Medicare Part D (2008) (0)
- Are the Young Becoming More Disabled ? Appendix (2003) (0)
- Book Review Shredding the Social Contract: The Privatization of Medicare By John Geyman. 322 pp., illustrated. Monroe, Me., Common Courage Press, 2006. $16.95. 1-56751-376-X (2006) (0)
- Comparing Medical Productivity between Germany and the US (2008) (0)
- Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimens. (2012) (0)
- Regulating Drug Prices (2008) (0)
- The Long-term Value of Bariatric Surgery Interventions for American Adults With Type 2 Diabetes Mellitus (2022) (0)
- Life course inequality across generations (2017) (0)
- PRESIDENTIAL SYMPOSIUM: THE HARTFORD AGING SOCIETY INDEX (2017) (0)
- Table 27, Mean per beneficiary payments for non-RVU services, 1993 and 1998 (2003) (0)
- Can Immigrants Solve Our Health Care Problems (2010) (0)
- Market Exclusivity For Drugs: The Authors Reply (2011) (0)
- Table 9, Year-to-year percentage increase in health expenditure (all payers) (2003) (0)
- Legal Status And Health Insurance Among Immigrants It is one's education, income, and place of employment that matter, not one's place of birth. (2005) (0)
- Construct validity of the SF-12 in type-1 diabetes (2013) (0)
- Productivity Bene fi ts of Medical Care : Evidence from US-Based Randomized Clinical Trials (2018) (0)
- 1993 Two-part Model Estimation Results (2003) (0)
- Health Care In California. (2018) (0)
- Table 13, Total Medicaid expenditure on physician, clinical, and other professional services, 1990-1999, in 1990 constant dollars (2003) (0)
- What Can We Learn about Hospitals from the Revealed Preferences of Patients (2008) (0)
- Table 3, Medicare volume performance standard and sustainable growth rate, performance adjustments and updates 1992-1998 (2003) (0)
- Participation o f P atients 6 5 Y ears o f A ge o r O lder i n Cancer C linical T rials (2003) (0)
- A Cautionary Tale in Comparative Effectiveness Research: Pitfalls and Perils of Observational Data Analysis (2017) (0)
- Life Expectancy Is Better Than Age as a General Predictor of Health Care Expenditures (2008) (0)
- 1993 OLS Model Estimation Results (2003) (0)
- The Economic Value of Medical Innovation (2012) (0)
- Table 24, Differences between predicted and actual use of RVUs for physician services in 1998, sorted from highest to lowest unexplained change (2003) (0)
- PCN92 THE WAR ON CANCER: AN ECONOMIC EVALUATION OF RECENT GAINS IN CANCER SURVIVAL (2008) (0)
- Editors' Summary (2010) (0)
- Table 29, Differences between predicted and actual use of and expenditures for anesthesia in 1993 and 1998 (2003) (0)
- Rising Medicare Costs (2006) (0)
- Table 18, Projected percentage increase in expenditures for physicians' services resulting from changes in law or regulations (2003) (0)
- Prescription Medication Abuse and Illegitimate Internet-Based (2015) (0)
- Introduction. Standard market mechanisms than does traditional Medicare. (2013) (0)
- Table 21, RVU consumption for physician services (2003) (0)
- Medicaid formulary restrictions and expenditures for patients with major depressive disorder (2014) (0)
- NBER WORKING PAPER SERIES THE PRAGMATIST’S GUIDE TO COMPARATIVE EFFECTIVENESS RESEARCH (2011) (0)
- The Impact of Regulation and Financial Incentives on Cost-of-Illness (1994) (0)
- MEDICARE‐FOR‐ALL: NOT OUR ONLY OPTION FOR UNIVERSAL COVERAGE (2018) (0)
- The Benefits of Greater Data Exclusivity under the Hatch-Waxman Act (2009) (0)
- Table 4, Services defined in Medicare Part B as physicians' services (1993-1998) (2003) (0)
- Clinical Trial Participation and Prescription Drug Use (2006) (0)
- 347-OR: The Long-Term Effects of an Intensive Lifestyle Intervention on Medicare Outcomes (2019) (0)
- POLICY AND PROGRAM RECOMMENDATIONS FOR AN AGING SOCIETY (2017) (0)
- Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data (2010) (0)
- Do Commercial Health Care Prices Influence Medicare Spending (2018) (0)
- Table 23, RVU for physician services use by year (2003) (0)
- Table 16, Total Medicare expenditure on physician services, 1990-1998, in 1990 constant dollars (2003) (0)
- Access/Use of Services Access of Vulnerable Groups to Antiretroviral Therapy Among Persons in Care for HIV Disease in the United States (2005) (0)
- The Long-Term Social Value Of Better Targeting G-Csf Therapy To Cancer Patients At Risk Of Febrile Neutropenia (2018) (0)
- Erratum (1997) (0)
- Medicare Facts and Figures (2006) (0)
- Technological Advance in Cancer and the Future of Medical Care Expenditures by the Elderly (2019) (0)
- The Role of Specialty Drugs in Private Sector Healthcare Spending (2013) (0)
- Health Care Costs And Clinical Outcomes Associated With Rates Of Sulfonylurea Use By Physicians (2013) (0)
- Decomposing the Change in Medicare Expenditures for Physicians' Services (2003) (0)
- Table 2, Expenditure targets and performance adjustment factors that determined update factors between 1992 and 1998 (2003) (0)
- PHP40 Hospital Spending and Inpatient Mortality (2012) (0)
- Table 15, Average annual Medicare expenditure growth rates by provider sector: before and after the Balanced Budget Act (2003) (0)
- Table 5, Medicare volume performance standard, 1990-1997, and sustainable growth rate 19981 (2003) (0)
- The changing face of pharmacy benefit design: Aa small group of pharmacy benefit experts suggests that changes could be coming for tiered copayment designs (2004) (0)
- POLICY Employee Responses to Health Insurance Premium Increases (2013) (0)
- Health Affairs Capacity Is A Concern Broad Hepatitis C Treatment Scenarios Return Substantial Health Gains , But Dieterich and (2015) (0)
- [Table], Table: RVU for physician services use 1993 and 1998 (2003) (0)
- Medical Care Costs of Patients with Amyotrophic Lateral Sclerosis in the Medicare Program (P07.065) (2013) (0)
- Value of Cancer Spending (2012) (0)
- Table 26, Differences between predicted and actual use of RVUs in 1998, outpatient (2003) (0)
- Actual Characteristics of the 1993 FFS, 1993 HMO, 1998 FFS, and 1998 HMO Samples (2003) (0)
- Estimating the Effects of Extended-Release Formulations on Adherence, HBA1C Control and Hospital Outcomes (2018) (0)
- Table 12, Total and per person private insurance and out-of-pocket expenditures, 1990-1999, in 1990 constant dollars (2003) (0)
- Response to Epstein's comment on "heterogeneity in action". (2014) (0)
- The Returns to Preventing Chronic Disease in Europe and the United States (2022) (0)
- Legislative Changes to Prices and Coverage, 1994-1998 (2003) (0)
- High Out-of-Pocket Medical Expenditures of Medicare Beneficiaries (2003) (0)
- Do multiple sclerosis cost-effectiveness studies follow best practice guidelines? A review of 5 case studies (P3.399) (2017) (0)
- Patients’ Willingness To Pay: The Authors Reply (2012) (0)
- PIH24 Modeling the Health and Medical Care Spending of the Future Elderly: An Update Using the Future Elderly Model (2012) (0)
- PDB77 INCREASED SURVIVAL IN THE MEDICARE FEE-FOR-SERVICE POPULATION ASSOCIATED WITH IMPROVED OUTCOMES IN PEOPLE WITH DIABETES (2020) (0)
- [Table, 1993 Two-part Model Estimation Results]. (2003) (0)
- Table 7, Average annual percentage change in all conversion factors (2003) (0)
- Evaluating Health Care Reform Using the Healt and Retirement Survey: A Case Study of the Health Security Act of 1993 (1994) (0)
- HIV Treatment and Risky Sexual Behavior (2005) (0)
- Correspondence regarding "A benefit-based copay for prescription drugs" [1] (multiple letters) (2002) (0)
- Medicare Facts and Figures Chartbook (2010) (0)
- Correction for Barcellos et al., Preparedness of Americans for the Affordable Care Act (2015) (0)
- Pharmacy Benefit Caps And The Chronically Ill Some U.S. retirees are vulnerable to high drug spending and might drop the use of beneficial drugs if their benefits are capped. (2007) (0)
- Extending Health Care Insurance to Specific Populations: Profile of RAND Work (2000) (0)
- Authors’ reply to Bosco-Lévy and Salvo (2016) (0)
- MortalityandTreatmentPatternsAmongPatients HospitalizedWithAcuteCardiovascularConditions DuringDatesofNationalCardiologyMeetings (2014) (0)
- The Future of the Elderly Population Health Status: Filling a Knowledge Gap (2020) (0)
- Racial and Ethnic Difference in Response to the Medicare Part D Coverage Gap (2015) (0)
- Table 28, Differences between predicted and actual use of and expenditures for diagnostic labs and x-rays in 1993 and 1998 (2003) (0)
- Political polarization in US residents’ COVID-19 risk perceptions, policy preferences, and protective behaviors (2020) (0)
- Health care resource utilization Any inpatient visits Any specialist visits Number of outpatient visits Months supplied of Rx Elixhauser comorbidities Valvular disease Pulmonary circulation disorder Peripheral vascular disorder Other neurological Chronic pulmonary disease Hypothyroidism Renal failur (2014) (0)
- PND37 PROJECTING THE BURDEN OF ALZHEIMER'S DISEASE AND EVALUATING THE POTENTIAL IMPACTS OF PREVENTING ALZHEIMER'S DISEASE IN THE UNITED STATES (2010) (0)
- Table 17, Annual Medicare expenditures per enrollee, 1990-1999, in 1990 constant dollars (2003) (0)
- Improving Patient-Centered Care in Diabetes With Comparative Effectiveness Research (2013) (0)
- Commentary (Goldman): Evaluating the Total Costs of Cancer (2003) (0)
- Health ' Advantage ' Of Recent Mexican Immigrants Undiagnosed Disease , Especially Diabetes , Casts Doubt On Some Of Reported (2012) (0)
- Community-Acquired Pneumonia and Proton Pump Inhibitors (2013) (0)
- Table 6, Physician fee schedule updates and conversion factors by service type, 1993-1998 (2003) (0)
- Adverse Selection in Prescription Drug Plans (2007) (0)
- Major Changes to Medicare Would Cut Costs but Also Squeeze Enrollment and Raise Spending for Seniors (2013) (0)
This paper list is powered by the following services:
Other Resources About Dana Goldman
What Schools Are Affiliated With Dana Goldman?
Dana Goldman is affiliated with the following schools:
